Kiniksa Pharmaceuticals International Income Statement (2017-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	12.10M	18.75M	32.19M	26.97M	99.14M	-148.30M	48.34M	71.47M	67.05M	83.39M	79.86M	108.63M	112.21M	122.54M	137.78M	156.80M	180.85M	202.13M	214.27M	243.60M
Cost of Revenue (Quarter)	2.77M	3.87M	4.22M	5.03M	6.94M	6.71M	0.49M	7.70M	9.09M	9.58M	10.58M	12.32M	20.11M	17.90M	17.87M	18.60M	20.26M	20.95M	20.80M	23.57M
Gross Profit (Quarter)	9.33M	14.88M	27.97M	21.94M	92.20M	-155.01M	47.85M	63.77M	57.96M	73.81M	69.28M	96.31M	92.11M	104.64M	119.92M	138.19M	160.60M	181.18M	193.47M	220.03M
Operating items
Research & Development (Quarter)	19.24M	27.43M	20.82M	13.80M	16.48M	14.39M	15.17M	23.77M	17.11M	20.05M	26.33M	24.02M	26.06M	35.22M	17.00M	18.75M	24.17M	34.61M	27.48M	40.90M
Selling, General & Administrative (Quarter)	20.76M	22.74M	22.22M	23.84M	24.68M	27.21M	29.05M	29.18M	34.47M	36.74M	38.68M	42.40M	46.40M	40.53M	43.53M	46.86M	49.10M	56.77M	61.15M	63.87M
Other Operating Expenses (Quarter)	2.77M	4.70M	12.47M	8.70M	11.56M	14.23M	15.32M	21.68M	26.40M	26.52M	31.38M	42.34M	49.42M	66.08M	63.98M	71.02M	83.56M	90.97M	96.37M	111.64M
Operating Expenses (Quarter)	42.76M	54.88M	55.51M	46.34M	52.72M	55.84M	59.54M	74.63M	77.97M	83.31M	96.40M	108.75M	121.87M	141.84M	124.51M	136.64M	156.83M	182.36M	185.00M	216.41M
Operating Income (Quarter)	-30.67M	-36.13M	-23.32M	-19.37M	46.41M	6.05M	-11.20M	-3.15M	-10.93M	0.08M	-16.54M	-0.12M	-9.66M	-19.30M	13.27M	20.16M	24.02M	19.77M	29.27M	27.19M
EBIT (Quarter)	-30.67M	-36.13M	-23.32M	-19.37M	46.41M	6.05M	-11.20M	-3.15M	-10.93M	0.08M	-16.54M	-0.12M	-9.66M	-19.30M	13.27M	20.16M	24.02M	19.77M	29.27M	27.19M
Non-operating items
Interest & Investment Income (Quarter)	-0.07M	-0.05M	-0.04M	0.01M	0.02M	0.11M	0.01M	-0.04M	-0.01M	0.01M	-0.06M	-0.08M	0.09M	-0.12M	-0.00M	0.11M	-0.10M	0.13M	-0.64M	-0.71M
Other Non Operating Income (Quarter)			0.03M	0.10M	0.32M	0.79M	1.83M	1.92M	2.43M	2.37M	2.27M	2.42M	2.46M	2.32M	2.29M	2.72M	3.14M	3.50M	3.41M	3.95M
Net income details
EBT (Quarter)	-30.66M	-43.80M	-23.29M	-19.27M	46.73M	90.91M	-9.36M	-1.24M	-8.50M	-72.03M	-14.28M	2.30M	-7.20M	-16.98M	15.56M	22.88M	27.16M	23.27M	32.68M	31.14M
Tax Provisions (Quarter)	-0.12M	0.28M	1.93M	0.72M	-177.36M	2.38M	2.91M	-16.21M	5.36M	-22.79M	3.43M	6.21M	5.49M	-8.09M	7.03M	5.04M	8.72M	9.07M	10.09M	5.71M
Profit After Tax (Quarter)	-30.62M	-36.35M	-25.21M	-19.98M	224.11M	4.57M	-12.27M	14.97M	-13.87M	25.28M	-17.70M	-3.91M	-12.69M	-9.01M	8.54M	17.94M	18.43M	14.33M	22.59M	25.43M
Income from Continuing Operations (Quarter)	-30.54M	-44.08M	-25.21M	-19.98M	224.09M	88.53M	-12.27M	14.97M	-13.86M	-49.24M	-17.70M	-3.91M	-12.69M	-8.89M	8.54M	17.83M	18.43M	14.20M	22.59M	25.43M
Consolidated Net Income (Quarter)	-30.54M	-44.08M	-25.21M	-19.98M	224.09M	88.53M	-12.27M	14.97M	-13.86M	-49.24M	-17.70M	-3.91M	-12.69M	-8.89M	8.54M	17.83M	18.43M	14.20M	22.59M	25.43M
Income towards Parent Company (Quarter)	-30.54M	-44.08M	-25.21M	-19.98M	224.09M	88.53M	-12.27M	14.97M	-13.86M	-49.24M	-17.70M	-3.91M	-12.69M	-8.89M	8.54M	17.83M	18.43M	14.20M	22.59M	25.43M
Net Income towards Common Stockholders (Quarter)	-30.54M	-44.08M	-25.21M	-19.98M	224.09M	88.53M	-12.27M	14.97M	-13.86M	-49.24M	-17.70M	-3.91M	-12.69M	-8.89M	8.54M	17.83M	18.43M	14.20M	22.59M	25.43M
Additional items
EPS (Basic) (Quarter)	-0.44	-0.64	-0.36	-0.29	3.23	1.28	-0.18	0.21	-0.20	-0.70	-0.25	-0.06	-0.18	-0.12	0.12	0.24	0.25	0.19	0.30	0.33
EPS (Diluted) (Quarter)	-0.44	-0.64	-0.36	-0.29	3.18	1.26	-0.18	0.21	-0.20	-0.68	-0.25	-0.06	-0.18	-0.12	0.11	0.23	0.23	0.18	0.27	0.30
Shares Outstanding (Quarter)	68.66M	68.58M	69.14M	69.29M	69.45M	69.38M	69.75M	69.92M	70.19M	70.06M	70.63M	71.00M	71.73M	71.42M	72.65M	73.44M	74.71M	74.20M	76.52M	77.58M
Shares Outstanding (Diluted) (Quarter)	68.66M	68.58M	69.14M	69.29M	70.55M	70.42M	69.75M	71.63M	70.19M	71.92M	70.63M	71.00M	71.73M	71.42M	76.15M	77.94M	80.04M	78.98M	82.41M	83.40M
Shares Outstanding (Entity) (Quarter)	68.89M	69.06M	69.27M	69.43M	69.52M	69.70M	69.83M	70.00M	70.32M	70.46M	70.82M	71.08M	72.16M	72.52M	72.80M	74.03M	75.42M	76.29M	76.69M	77.98M
EBITDA (Quarter)	-30.67M	-36.13M	-23.32M	-19.37M	46.41M	6.05M	-11.20M	-3.15M	-10.93M	0.08M	-16.54M	-0.12M	-9.66M	-19.30M	13.27M	20.16M	24.02M	19.77M	29.27M	27.19M
Interest Expenses (Quarter)	14.25M	127.94M				19.58M		15.82M	15.08M	54.65M		0.01M	0.00M	62.33M	0.00M	0.03M	0.01M	0.00M	0.68M	1.38M
Tax Rate (Quarter)	0.38%	-0.64%	-8.27%	-3.72%	-379.50%	2.62%	-31.03%	1,308.39%	-63.02%	31.63%	-24.01%	269.62%	-76.27%	47.65%	45.14%	22.05%	32.12%	38.98%	30.87%	18.34%

Research Tools

Datasets

Plans

Developers

Kiniksa Pharmaceuticals International KNSA Income Statement (2017-2026)

Research Tools

Datasets

Plans

Developers

Kiniksa Pharmaceuticals International KNSA Income Statement (2017-2026)

Create an account

Sign In

Reset Password